Because Mesoblast is a global leader in cell therapy and research. Any activity in this space and progress especially commentary out of the fda and approvals in this space must be considered when looking at the progress of the overall sector of regenerative medicine.
To ignore the activity and commentary in this space for its therapeudic benefits wouldn't be prudent.
I remain positive on this sector and on Mesoblast's leading involvement in this space.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-9
- There are more pages in this discussion • 17,573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
0.060(12.1%) |
Mkt cap ! $633.0M |
Open | High | Low | Value | Volume |
50.0¢ | 59.0¢ | 48.5¢ | $16.88M | 30.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 99223 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 44000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 99223 | 0.555 |
12 | 129157 | 0.550 |
5 | 107360 | 0.545 |
16 | 329826 | 0.540 |
2 | 67148 | 0.535 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 44000 | 4 |
0.565 | 310 | 1 |
0.570 | 164673 | 5 |
0.575 | 43000 | 3 |
0.580 | 226348 | 7 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
55.5¢ |
  |
Change
0.060 ( 15.7 %) |
|||
Open | High | Low | Volume | ||
50.5¢ | 59.0¢ | 48.5¢ | 11524458 | ||
Last updated 16.02pm 28/03/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online